Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Lyka Labs Limited (NSE: LYKALABS), ISIN INE933A01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LYKALABS last traded at ₹86.20 (-0.58%), with a 52-week range of ₹44.49 to ₹104.80 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 58.45%, FIIs 0.17%, DIIs 0.66%, mutual funds 0.01%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.